Rabbit ventricular myocardium undergoing simulated ischemia and reperfusion in a double compartment tissue bath: A model to investigate both antiarrhythmic and arrhythmogenic likelihood

International Journal of Physiology, Pathophysiology and Pharmacology

Volumn 5, Issue 1, 2013, Pages 52-60

  Alexandre, Joachim ^a   Schiariti, Michele ^b   Rouet, René ^c   Puddu, Paolo Emilio ^b  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c France   (France)

Author keywords

Action potentials; Electrophysiology in vitro; Guine pig; Rabbit; Repetitive responses; Simulated ischemia; Ventricular myocardium

Indexed keywords

ACTION POTENTIAL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GUINEA PIG; HEART ARRHYTHMIA; HEART BEAT; HEART ELECTROPHYSIOLOGY; HEART MUSCLE; HEART VENTRICLE; MEMBRANE POTENTIAL; NONHUMAN; RABBIT; REPERFUSION INJURY;

EID: 84875030450     PISSN: None     EISSN: 19448171     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Picard S, Rouet R, Monti F, Puddu PE, Ducouret P, Flais F, Libersa C, Gérard JL. Proarrhythmic effects of dl-and d-sotalol on the "border zone" between normal and ischemic regions of isolated ventricular myocardium and antiar-rhythmic effects on reperfusion. J Cardiovasc Pharmacol 1998; 31: 126-139.
2. Rouet R, Picard S, Libersa C, Ghadanfar M, Alabaster C, Gérard JL. Electrophysiological effects of dofetilide in an in vitro model of "border zone" between normal and ischaemic/ reperfused myocardium. Circulation 2000; 101: 86-93.
3. Ducroq J, Rouet R, Puddu PE, Sallé L, Tabourel C, Ducouret P, Gérard JL. Electrophysiological effects of azimilide in an in vitro model of simulated-ischemia and reperfusion in guinea-pig ventricular myocardium. Eur J Pharmacol 2005; 518: 165-174.
4. o in an in vitro model of simulated-ischemia and reperfusion in guinea-pig ventricular myocardium. Eur J Pharmacol 2006; 532: 279-289.
5. Ks blockade in border zone arrhythmias from guinea-pig ventricular myocardium submitted to simulated ischemia and reperfusion. Fund Clin Pharmacol 2012; 26: 445-453.
6. Jouve R, Puddu PE, Langlet F, Guillen JC, Serradimigni A. The circumflex coronary occlusion canine model of sudden death: methodology and electrocardiographic observations. J Electrocardiol 1986; 19: 155-164.
7. Jouve R, Langlet F, Puddu PE, Guillen JC, Cano JP, Serradimigni A. Cicletanide improves outcome after left circumflex coronary artery occlusion-reperfusion in the dog. J Cardiovasc Pharmacol 1986; 8: 208-215.
8. Cano JP, Guillen JC, Jouve R, Langlet F, Puddu PE, Rolland PH, Serradimigni A. Molsidomine prevents post-ischemic ventricular fibrillation in dog. Br J Pharmacol 1986; 88: 779-789.
9. Morena H, Janse MJ, Fiolet JWT, Krieger WJG, Crijns H, Durrer D. Comparison of the effects of regional ischemia, hypoxia, hyperkalemia and acidosis on intracellular and extracellular potentials and metabolism in isolated porcine heart. Circ Res 1990; 46: 634-646.
10. Schiariti M, Puddu PE, Rouet R. Multivariate prediction of spontaneous repetitive responses in ventricular myocardium exposed in vitro to simulated ischemic conditions. Int J Cardiol 1994; 45: 9-22.
11. KS blockade and arrhythmogenicity in rabbit normoxic Purkinje fibres: does it really make a difference? Fund Clin Pharmacol 2011; 25: 304-312.
12. Thomsen MB, Matz J, Volders PG, Vos MA. Assessing the proarrhythmic potential of drugs: current status of models and surrogate parameters of torsades de pointes arrhythmias. Pharmacol Ther 2006; 112: 150-170.
13. Lu HR, Marien R, Saels A, De Clerck F. Species plays an important role in drug-induced prolongation of action potential duration and early afterdepolarizations in isolated Purkinje fibres. J Cardiovasc Electrophysiol 2001; 12: 93-102.
14. Puddu PE, Rouet R, Morel M. Systèmes d'acquisition de potentiels d'action: comment mesurer les Vmax élevées? Thérapie 2010; 65: 491-498.
15. D'Agostino RB, Chase W, Belanger A. The Appropriateness of some common procedures for testing the equality of two independent binomial populations. Am Stat 1988; 42: 198-202.
16. Ks. Am J Physiol 1996; 271: H2477-H2489.
17. Jost N, Papp JG, Varró A. Slow delayed rectifier potassium current (IKs) and the repolarization reserve. Ann Noninvasive Electrocardiol 2007; 12: 64-78.
18. Ks. Br J Pharmacol 2010; 159: 93-101.
19. + current block by HMR 1556 increases dispersion of repolarization and promotes Torsades de Pointes in rabbit ventricles. Br J Pharmacol 2008; 155: 1185-1194.
20. Cheng HC, Incardona J. Models of torsades de pointes: effects of FPL64176, DPI201106, dofetilide, and chromanol 293B in isolated rabbit and guinea pig hearts. J Pharmacol Toxicol Methods 2009; 60: 174-184.
21. Waldo AL, Camm AJ, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF, Pitt B, Pratt CM, Schwartz PJ, Veltri EP. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet 1996; 348: 7-12.
22. Køber L, Bloch Thomsen PE, Møller M, Torp-Pedersen C, Carlsen J, Sandøe E, Egstrup K, Agner E, Videbaek J, Marchant B, Camm AJ; Danish Investigations of Arrhythmia and Mortality on Dofetilide (DIAMOND) Study Group. Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial. Lancet 2000; 356: 2052-2058.
23. Salata JJ, Brooks RR. Pharmacology of azimilide dihydrochloride (NE-10064), a class III antiarrhythmic agent. Cardiovasc Drug Rev 1997; 15: 137-156.
24. Fermini B, Jurkiewicz NK, Jow B, Guinosso PJ Jr, Baskin EP, Lynch JJ Jr, Salata JJ. Use dependent effects of the class III antiarrhythmic agent NE-10064 (azimilide) on cardiac repolarization: block of delayed rectifier potassium and L-type calcium currents. J Cardiovasc Pharmacol 1995; 26: 259-271.
25. Camm AJ, Pratt CM, Schwartz PJ, Al-Khalidi HR, Spyt MJ, Holroyde MJ, Karam R, Sonnenblick EH, Brum JM; AzimiLide post Infarct surVival Evaluation (ALIVE) Investigators. Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification. Circulation 2004; 109: 990-996.
26. Picard S, Rouet R, Ducouret P, Puddu PE, Flais F, Criniti A, Monti F, Gérard JL. K channels ATP and 'border zone' arrhythmias: role of the repolarization dispersion between normal and ischaemic ventricular regions. Br J Pharmacol 1999; 127: 1687-1695.
27. Kay M, Swift L, Martell B, Arutunyan A, Sarvazyan N. Locations of ectopic beats coincide with spatial gradients of NADH in a regional model of low-flow reperfusion. Am J Physiol 2008; 294: H2400-H2405.
28. Sicouri S, Glass A, Ferreiro M, Antzelevitch C. Transseptal dispersion of repolarization and its role in the development of torsade de pointes arrhythmias. J Cardiovasc Electrophysiol 2010; 21: 441-447.